生物科技

Chinese genetics company targets US despite political tensions
華大智造未因政治緊張放棄進軍美國

MGI Tech insists it can succeed even though parts of its former parent BGI Group have been blacklisted
儘管前母公司的幾家子公司被美國列入了實體清單,這家生產基因測序儀的中國公司仍有信心打開美國市場。

China’s MGI Tech said it would press ahead with the US rollout of its gene sequencing machines as it was “completely different” from its former parent group, which has been blacklisted in the US.

中國的華大智造(MGI Tech)表示將繼續推進在美國開售其基因測序儀的事宜,因爲它與被美國列入黑名單的前母公司「完全不同」。

您已閱讀4%(258字),剩餘96%(6928字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×